Innocoll is dedicated to making better happen – striving to engineer better medicines to transform today’s treatment approaches.
Our proprietary, biocompatible, and biodegradable collagen-based products are engineered for targeted use. Applied locally, they are designed to provide a range of treatment benefits.
Our late-stage product pipeline is focused on addressing the significant unmet medical need for postsurgical pain management. XARACOLL, a bupivacaine HCI collagen-matrix implant, has been studied in two Phase III clinical trials for postsurgical analgesia as a part of multi-modal therapy for patients undergoing hernia repair.
Our currently approved products include: COLLAGUARD® (ex-US), COLLATAMP® G, SEPTOCOLL® E, REGENEPRO®, COLLACARE®, COLLEXA®, and ZORPREVA®, some of which are sold globally through strategic partnerships. All of our collagen products—from extraction/purification of Type 1 collagen through final delivery— are manufactured at our certified, integrated plant in Saal, Germany.